pVHL19 is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiation
AUTOR(ES)
Iliopoulos, Othon
FONTE
The National Academy of Sciences
RESUMO
The von Hippel–Lindau (VHL) gene encodes a protein consisting of 213 amino acid residues with an apparent molecular mass of 30 kDa (pVHL30). Here we show that cells also produce a VHL protein (pVHL19) that appears to arise as a result of internal translation from the second methionine within the VHL ORF. pVHL30 resides primarily in the cytosol, with less amounts found in the nucleus or associated with cell membranes. In contrast pVHL19, in biochemical fractionation experiments, is equally distributed between the nucleus and cytosol and is not found in association with membranes. pVHL19, like pVHL30, can bind to elongin B, elongin C, and Hs-Cul2 in coimmunoprecipitation assays and can inhibit the production of hypoxia-inducible proteins such as vascular endothelial growth factor (VEGF) and GLUT1 when reintroduced into renal carcinoma cells that lack a wild-type VHL allele. Thus, cells contain two biologically active VHL gene products.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=21697Documentos Relacionados
- Diverse Effects of Mutations in Exon II of the von Hippel-Lindau (VHL) Tumor Suppressor Gene on the Interaction of pVHL with the Cytosolic Chaperonin and pVHL-Dependent Ubiquitin Ligase Activity
- Von Hippel-Lindau disease.
- A second major native von Hippel–Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor
- Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
- Identificação e caracterização de mutações germinativas no gene VHL em famílias com a doença de von Hippel-Lindau